Metabolic dysfunction-associated fatty liver disease is associated with increased all-cause mortality in the United States
Background & Aims Recently, international experts proposed redefining non-alcoholic fatty
liver disease (NAFLD) as metabolic dysfunction-associated fatty liver disease (MAFLD),
based on modified criteria. It is suspected that outcomes such as mortality may differ for
these clinical entities. We studied the impact of MAFLD and NAFLD on all-cause and cause-
specific mortality in US adults. Methods We analyzed data from 7,761 participants in the
Third National Health and Nutrition Examination Survey and their linked mortality through …
liver disease (NAFLD) as metabolic dysfunction-associated fatty liver disease (MAFLD),
based on modified criteria. It is suspected that outcomes such as mortality may differ for
these clinical entities. We studied the impact of MAFLD and NAFLD on all-cause and cause-
specific mortality in US adults. Methods We analyzed data from 7,761 participants in the
Third National Health and Nutrition Examination Survey and their linked mortality through …
